Gritstone bio, Inc.
Case Number:
1:24-bk-12305
Court:
Nature of Suit:
Firms
Companies
Sectors & Industries:
-
November 13, 2024
Gritstone Bio Can Tap $25M New DIP As It Works Toward Sale
Vaccine developer Gritstone bio Inc. won a Delaware bankruptcy judge's approval Wednesday to borrow $25 million in new financing to support itself in Chapter 11 as the biotechnology company works to find a buyer.
-
November 05, 2024
The Story Behind Vaccine Maker Gritstone's Ch. 11
Vaccine maker Gritstone bio Inc. hit Chapter 11 after a tightening investment market left it starved of the capital it needed to keep doing its research into preventative treatments for cancer, COVID-19 and HIV, according to court filings.
-
November 04, 2024
Meet The Attys Behind Biotech Co. Gritstone's Ch. 11
Vaccine developer Gritstone bio Inc. has tapped a team of lawyers from Pachulski Stang Ziehl & Jones LLP and Fenwick & West LLP to help it navigate the Chapter 11 process while it angles to sell its business so its research can continue.
-
October 16, 2024
Catching Up With New Bankruptcy Case Action
Several companies including True Value, Accuride and Jordan Health filed for Chapter 11 bankruptcy over the past week, citing financial strains from inflation, supply-chain issues and market changes.